What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q2 2021?

190 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 251,185,504
Total 13F shares: 104,615,646
Share change: -31,536
Total reported value: $1,653,902,810
Put/Call ratio: 105%
Price per share: $15.81
Number of holders: 190
Value change: +$25,597,252
Number of buys: 96
Number of sells: 94

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.5%	16,241,775	$165,180,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	5.1%	12,710,818	$129,269,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	3.9%	9,700,067	$98,648,000	—	31 Mar 2021	13F
Sarissa Capital Management LP	13F	Company	3%	7,637,700	$77,675,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	2.9%	7,308,816	$74,331,000	—	31 Mar 2021	13F
HealthCor Management, L.P.	13F	Company	1.9%	4,886,440	$49,695,000	—	31 Mar 2021	13F
Artisan Partners Limited Partnership	13F	Company	1.2%	3,025,606	$30,770,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	2,990,523	$30,413,000	—	31 Mar 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1%	2,605,380	$26,497,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	1%	2,504,355	$25,469,000	—	31 Mar 2021	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.94%	2,367,670	$24,079,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.86%	2,170,590	$22,075,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.83%	2,094,445	$21,301,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.78%	1,952,128	$19,853,000	—	31 Mar 2021	13F
STIFEL FINANCIAL CORP	13F	Company	0.74%	1,850,354	$18,818,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.72%	1,800,000	$18,306,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.57%	1,433,838	$14,582,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.54%	1,349,119	$13,721,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	1,206,966	$12,275,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.34%	865,538	$8,803,000	—	31 Mar 2021	13F
Burrage Capital Management LLC	13F	Company	0.34%	864,916	$8,796,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.32%	807,612	$8,213,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.32%	806,386	$8,201,000	—	31 Mar 2021	13F
Bain Capital Public Equity Management II, LLC	13F	Company	0.29%	718,730	$7,309,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.28%	714,901	$7,270,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.27%	685,484	$6,971,000	—	31 Mar 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.2%	500,000	$5,085,000	—	31 Mar 2021	13F
Lisanti Capital Growth, LLC	13F	Company	0.19%	472,520	$4,806,000	—	31 Mar 2021	13F
North Star Investment Management Corp.	13F	Company	0.17%	435,790	$4,432,000	—	31 Mar 2021	13F
Granahan Investment Management, LLC	13F	Company	0.17%	429,902	$4,372,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.16%	403,468	$4,103,000	—	31 Mar 2021	13F
Integral Health Asset Management, LLC	13F	Company	0.16%	400,000	$4,068,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.16%	392,073	$3,988,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.15%	388,697	$3,953,000	—	31 Mar 2021	13F
Sofinnova Investments, Inc.	13F	Company	0.15%	378,774	$3,852,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.14%	362,165	$3,683,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.14%	359,300	$3,654,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.11%	268,900	$2,735,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	266,467	$2,710,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.11%	266,359	$2,709,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.1%	263,584	$2,681,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.1%	257,207	$2,616,000	—	31 Mar 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.1%	244,680	$2,488,000	—	31 Mar 2021	13F
CREDIT SUISSE AG/	13F	Company	0.09%	236,047	$2,400,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.09%	235,293	$2,393,000	—	31 Mar 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.09%	233,413	$2,373,810	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	224,212	$2,280,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.08%	211,950	$2,156,000	—	31 Mar 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.08%	211,407	$2,150,000	—	31 Mar 2021	13F
DG Capital Management, LLC	13F	Company	0.08%	203,337	$2,068,000	—	31 Mar 2021	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2021

As of 30 Jun 2021, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 190 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,615,646 shares. The largest 10 holders included BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, Sarissa Capital Management LP, HealthCor Management, L.P., Artisan Partners Limited Partnership, GEODE CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Nuveen Asset Management, LLC. This page lists 190 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

183

Q2 2021 holders

190

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.